APA (7th ed.) Citation

Lyu, J., Okada, H., Sunagozaka, H., Kawaguchi, K., Shimakami, T., Nio, K., . . . Honda, M. (2024). Potential utility of l-carnitine for preventing liver tumors derived from metabolic dysfunction-associated steatohepatitis. Hepatology communications, 8(5), . https://doi.org/10.1097/HC9.0000000000000425

Chicago Style (17th ed.) Citation

Lyu, Junyan, et al. "Potential Utility of L-carnitine for Preventing Liver Tumors Derived from Metabolic Dysfunction-associated Steatohepatitis." Hepatology Communications 8, no. 5 (2024). https://doi.org/10.1097/HC9.0000000000000425.

MLA (9th ed.) Citation

Lyu, Junyan, et al. "Potential Utility of L-carnitine for Preventing Liver Tumors Derived from Metabolic Dysfunction-associated Steatohepatitis." Hepatology Communications, vol. 8, no. 5, 2024, https://doi.org/10.1097/HC9.0000000000000425.